Omniphar SRL
1.8 FTEOmniphar reported total assets of 369,071 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Jul 2026), with 1.8 full-time equivalent.
The score of Omniphar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -15 % Headcount (avg FTE) -10 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Omniphar's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −38,387 € | ||||
| Equity | −187,834 € | ||||
| Cash | 50,820 € | ||||
| EBITDA | −9,885 € | ||||
| Total assets | 369,071 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Jul 2026
- Year ended 31 Dec 2024filed on 25 Jul 2025
- Year ended 31 Dec 2023filed on 28 Aug 2024
- Year ended 31 Dec 2022filed on 24 Jul 2023
- Year ended 31 Dec 2021filed on 08 Jul 2022
Omniphar's financial analysis
- Solvency-50.9%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Omniphar
Omniphar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0880.522.349
- VAT number
- BE0880522349
- Peppol
- Registered · 0208:0880522349 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 05 Apr 2006
- Registered office
- 9600 Ronse
- Size
- Micro · 1.8 FTE
- Latest accounts
- 2025 · filed on 31 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Omniphar (SRL) has been based in Ronse since 2006, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 38,387 € and equity of −187,834 €; its revenue is not published. With 1.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -50.9%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Omniphar
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Besonrieux Centre Retail sale of pharmaceutical products La Louvière · balance sheet 377,209 €
- La Roue Pharma Retail sale of pharmaceutical products Anderlecht · balance sheet 369,361 €
- Pharbiomed Retail sale of pharmaceutical products Brussels · balance sheet 369,863 €
- Jumatex Retail sale of pharmaceutical products Saint-Josse-ten-Noode · balance sheet 369,879 €
- Bogest Retail sale of pharmaceutical products Liège · balance sheet 367,587 €
- Acura Pharma Retail sale of pharmaceutical products Brussels · balance sheet 366,408 €
- Family Pharma Retail sale of pharmaceutical products Brussels · balance sheet 372,644 €
- Pintelon Retail sale of pharmaceutical products Oostkamp · balance sheet 373,225 €
Frequently asked questions about Omniphar
What is the revenue of Omniphar?
Omniphar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Omniphar?
In Belgium, the VAT number is the company number prefixed with BE: BE0880522349 for Omniphar, if the company is VAT-registered. Its company number (CBE) is 0880.522.349.
Where is the registered office of Omniphar?
According to the CBE register, the registered office of Omniphar is in 9600 Ronse.
What is the equity of Omniphar?
At the close of the 2025 financial year, the equity of Omniphar amounts to -187,834 €, a solvency of -50.9% of total assets.
How many people work at Omniphar?
1.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Omniphar?
The register lists 2 active mandates at Omniphar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Omniphar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →